開設賬戶
模擬帳戶
關於我們
即時報價及新聞
市場分析
財經日曆
每日市場分析
交易平台
下載及介紹
使用教學
交易細則
各項細則
資金提存
推廣和資訊
常見問題
聯絡我們
繁
简
EN
客户登入
開設賬戶
模擬帳戶
繁
简
EN
客户登入
開設賬戶
模擬帳戶
關於我們
上志國際介紹
上志國際特點
即時報價及新聞
即時報價
即時新聞
市場分析
財經日曆
市場分析
交易平台
平台特點
平台教學
交易細則
各項細則
資金提存
推廣和資訊
常見問題
聯絡我們
關於我們
交易細則
貴金屬市場
交易平台
市場分析
推廣和資訊
常見問題
聯絡我們
繁
简
EN
市場消息:SpaceX擬通過高等級債券發行籌資250億美元。
2026-06-24
市場消息:SpaceX擬通過高等級債券發行籌資250億美元。
返回
其他消息
2026-06-23
South Korea’s KOSPI plunged 9.99% on Tuesday, the largest one-day drop in three months, after foreign investors sold following a regulator signal that the chip sector was overheating. CLSA chief equity strategist Alexander Redman said the move exposed heightened volatility driven by heavy retail participation and margin use, warning volatility "has gone out of control" and noting regulator-approved leveraged single-stock ETFs have amplified risks. South Korea’s market regulator acknowledged it w
South Korea’s KOSPI plunged 9.99% on Tuesday, the largest one-day drop in three months, after foreign investors sold following a regulator signal that the chip sector was overheating. CLSA chief equity strategist Alexander Redman said the move exposed heightened volatility driven by heavy retail participation and margin use, warning volatility "has gone out of control" and noting regulator-approved leveraged single-stock ETFs have amplified risks. South Korea’s market regulator acknowledged it was too hasty approving leveraged funds tied to major chip names launched last month and warned retail investors against using leverage as margin debt and financing to buy stocks hit a record high in June.
2026-06-23
Tianfang Pharmaceutical, a unit of Tongyong Technology China Pharmaceuticals, received an NMPA supplemental-approval notice for diclofenac sodium enteric-coated tablets after passing generic quality and efficacy consistency evaluation. Indications include inflammatory and degenerative rheumatic diseases, non-articular soft-tissue rheumatic pain, acute mild-to-moderate pain and acute gout attacks. The product is listed on China’s national reimbursement list (Category A).
Tianfang Pharmaceutical, a unit of Tongyong Technology China Pharmaceuticals, received an NMPA supplemental-approval notice for diclofenac sodium enteric-coated tablets after passing generic quality and efficacy consistency evaluation. Indications include inflammatory and degenerative rheumatic diseases, non-articular soft-tissue rheumatic pain, acute mild-to-moderate pain and acute gout attacks. The product is listed on China’s national reimbursement list (Category A).
Chat with us
, powered by
LiveChat